Bone marrow transplantation in Hong Kong

Area of Science:

• Hematology
• Oncology
• Transplant Medicine

Background:

• Bone marrow transplantation (BMT) programs in Hong Kong commenced in 1990.
• Currently, 13 BMT beds are available in government-funded university hospitals.
• Approximately 110 transplants are performed annually, equating to 18 transplants per million population.

Purpose of the Study:

• To review the initial outcomes and characteristics of bone marrow transplantation in Hong Kong.
• To assess the types of transplants performed and their indications.
• To compare local BMT results with international data.

Main Methods:

• Retrospective analysis of 194 bone marrow transplants performed between 1990 and September 1993.
• Categorization of transplants by donor type (allogeneic, autologous, unrelated, twin, mismatched, second BMT).
• Review of patient preparation methods, graft-versus-host disease (GVHD) prophylaxis, and outcomes.

Main Results:

• Hematological malignancy was the primary indication for 84% of transplants.
• Allogeneic BMT constituted the majority (72.2%) of procedures.
• Graft-versus-host disease incidence was comparable to Caucasian populations, with CsA and MTX as common prophylaxis.

Conclusions:

• Bone marrow transplant outcomes in Hong Kong are comparable to international standards.
• The program has established a significant capacity for treating hematological malignancies.
• Further development and data collection are warranted to optimize patient care.